CA
NZ
UK
AU
IND
US
Vista Energy, S.A.B. de C.V. filed a Form 6-K on November 9, 2026, disclosing a repurchase of 30,000 Series A shares on November 6, 2026, at a price of Mexican Pesos 1,068.97 per share.
Protalix BioTherapeutics, Inc. filed an 8-K press release on November 9, 2026, announcing the presentation of individual participant pharmacokinetic and pharmacodynamic data from the Phase 1 single ascending dose study of PRX-115 at the American College of Rheumatology Convergence 2026 in Orlando, Florida.
Denise Paulonis, President and CEO of Sally Beauty Holdings, Inc., filed a Form 4 on November 9, 2026, disclosing the acquisition of five tranches of restricted stock units on November 4, 2026, covering both newly granted RSUs and earned performance stock units.
WaFd, Inc. filed a Form 8-K on November 9, 2026, disclosing a letter agreement dated November 2, 2026, under which Chief Experience Officer Cathy E. Cooper will receive a $1,650,000 lump-sum cash payment tied to the company's pending merger with EverBank Financial Corp.
loanDepot, Inc. filed a current report on Form 8-K on November 9, 2026, announcing its financial results for the quarter ended September 30, 2026, and furnishing an investor presentation made available during the company's earnings conference call and webcast.
Somnigroup International Inc. filed an 8-K on November 9, 2026, reporting third-quarter financial results for the period ended September 30, 2026, including the first consolidated contribution from its acquisition of Leggett & Platt, Incorporated, completed on August 26, 2026.
Vivid Seats Inc. filed its quarterly report on Form 10-Q with the SEC on November 9, 2026, covering the three-month period ended September 30, 2026, and disclosing a decline in total assets, a wider accumulated deficit, and the delisting of its warrants from Nasdaq.
Companhia Siderúrgica Nacional (National Steel Company) filed a Form 6-K with the U.S. Securities and Exchange Commission on November 9, 2026, disclosing that it entered into a Share Purchase Agreement on November 8, 2026 to sell its cement subsidiary, CSN Cimentos Brasil S.A., to …
Abeona Therapeutics Inc. filed a Form 8-K with the SEC on November 9, 2026, disclosing a press release covering its financial results for the quarter ended September 30, 2026, and an investor presentation disseminated the same day.
ORIX Corporation filed a Form 6-K with the U.S. Securities and Exchange Commission on November 9, 2026, reporting consolidated financial results for the six months ended September 30, 2026, an interim dividend declaration, and a notice regarding equity method investment income recognition.
Please wait processing your request...